Adam K. Stern - 27 Jan 2026 Form 4 Insider Report for VivoSim Labs, INC. (VIVS)

Reporting relationship: Director
Issuer ticker: VIVS
Reported as of: 27 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Jan 2026, 19:47:16 UTC
Prior SEC filing: 13 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Norman Staskey, attorney-in-fact

Key filing fact

Adam K. Stern filed Form 4 for VivoSim Labs, INC. (VIVS) on 29 Jan 2026.

Key facts

This page summarizes Adam K. Stern's Form 4 filing for VivoSim Labs, INC. (VIVS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 29 Jan 2026, 19:47.

Change

Previous filing in this sequence was filed on 13 Aug 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001403497 Primary reporting owner

STERN ADAM K

Relationship: Director
Address: 11555 SORRENTO VALLEY ROAD SUITE 100, SAN DIEGO
Signature: /s/ Norman Staskey, attorney-in-fact
Signature date: 29 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VIVS transaction

Common Stock

Award

Transaction value: $0
Shares: +15,000
Change %: +306%
Price: $0.000000
Shares after: 19,899
Date: 27 Jan 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported securities are represented by restricted stock units, which shall vest on the earlier of January 27, 2027 or the date of the next annual meeting of stockholders held by the Issuer, subject to acceleration in the event of a change of control.

Footnote F2

Effective on March 20, 2025, the Issuer conducted a reverse stock split of its common stock at a ratio of 1-for-12 (the "Reverse Split"). All share numbers reported herein give effect to the Reverse Split.

SEC remarks

Exhibit 24 - Power of Attorney